OrbiMed

Dallas’ Forte Biosciences Announces $53M Private Placement From Leading Healthcare Investors

by | Nov 21, 2024
Headquartered at Dallas' Pegasus Park, Forte Biosciences is developing a proprietary molecule with potentially broad autoimmune and autoimmune-related applications.
MORE
Caris Life Sciences Raises $310M to Continue Rapidly Growing in the Precision Medicine Market
by | Oct 27, 2020
The growth capital will allow Caris to advance its position as a leading tumor profiling company that aims to reinvent cancer care.
MORE